At least in mouse models, co-delivery of a probiotic cocktail of Bifidobacterium strains improved the outcome of anti-PDL1 cancer therapy (130) and likewise Bacteroides thetaiotaomicron or Bacteroides fragilis transfer enhanced anti-CTLA-4 cancer therapy (128). This evidence concerns the gene CTLA4 and cancer.